Furthermore, they provide the first in vivo evidence that oxytocin modulates network topology in regions implicated in the pathophysiology of psychosis in a clinical status (CHR-P vs healthy control) specific manner, which strengthens the rationale for future studies investigating the therapeutic role of oxytocin in this clinical population. Here, OXT is linked to psychotic disorder.